Empagliflozin and Metformin Hydrochloride Tablet 12.5/1000 mg
Empagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Aju Pharmaceutical Co., Ltd.
MFDS item code 202302638 · Approved 2023.09.05
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used to help control blood sugar levels in adults with type 2 diabetes, alongside dietary and exercise therapy. It is particularly suitable when dual therapy with empagliflozin and metformin is needed and is effective for patients whose blood sugar levels are not adequately controlled. Additionally, it is used in patients with cardiovascular diseases, but in this case, precautions based on clinical trial information from specialists must be strictly followed. Overall, it assists in managing blood sugar levels and related cardiovascular risks in patients with type 2 diabetes.
The recommended dose is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of the individual components: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who are unable to achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin to this medicine should receive their current doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). Elderly patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication helps to control blood sugar. However, it can, although rarely, cause a serious condition known as lactic acidosis, which can be life-threatening, so caution is required. Also, when used with other diabetes medications, severe hypoglycemia can occur, necessitating careful monitoring of blood sugar levels. Patients with allergies to any of the ingredients in this medication or severely impaired kidney function should not use it. It is also not safe to administer during acute illnesses that can affect kidney function, such as severe dehydration, infections, heart problems, or acute myocardial infarction. This medication should not be administered to patients with type 1 diabetes, diabetic ketoacidosis, acute heart failure, or those scheduled for tests using radiopaque materials. Regular monitoring of kidney function is necessary before starting and during treatment with this medication, especially for elderly patients or those with mildly impaired kidney function, requiring more frequent checks. In situations where there is a risk of fluid loss, caution should be exercised when administering this medication, and the dosage of other medications like insulin or sulfonylureas may be adjusted to reduce the risk of hypoglycemia. While on this medication, side effects such as gastrointestinal disorders, hypoglycemia, urinary tract infections, genital infections, increased urination, nausea, vomiting, diarrhea, abdominal pain, loss of appetite, constipation, abnormal liver function tests, taste disturbances, erythema, thirst, increased serum lipids, increased serum creatinine, decreased glomerular filtration rate, decreased vitamin B12 concentration, headache, dizziness, weight loss, insomnia, fever, vascular stent stenosis, vascular stent thrombosis, upper respiratory infections, and facial edema may occur, so immediate consultation with a healthcare provider is advised if these symptoms arise. Women who are pregnant or may become pregnant, as well as nursing mothers, are advised not to use this medication unless necessary and should consult a specialist. Additionally, alcohol consumption can increase the risk of lactic acidosis, so excessive drinking should be avoided while taking this medication. In cases of impending surgery or acute illnesses, this medication should be discontinued 48 hours prior to the procedure and resumed only after kidney function has returned to normal. This medication poses a particularly high risk of fluid loss in elderly patients, necessitating careful attention and regular kidney function tests and symptom monitoring. In cases of overdose, treatments such as hemodialysis may be required, so accurate adherence to dosage is crucial, and if any unusual symptoms appear, immediate medical attention should be sought. To use this medication safely, it is important to follow the doctor's instructions carefully, undergo regular examinations, and promptly address any unusual symptoms.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to avoid exposure to air or moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius. This helps to ensure the medication's effectiveness and safety.
Biconvex oval film-coated tablet with a dark brownish-purple color on both sides.
Bottle packaging - 60 tablets/bottle, PTP packaging - 60 tablets/box [(10 tablets/PTP x 6)], PTP packaging - 10 tablets/box [(10 tablets/PTP x 1)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Aju Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.